Guerbet S.A Performance Comparison

Loading chart data...

Stock Range

Today's Range

Low: €13.54 High: €14.00
on October 6, 2025

52 Week Range

Low: €12.72 High: €39.35
on September 25, 2025
on October 21, 2024

All-Time High: €90.64 on March 27, 2017

Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights

Key Statistics

Market Cap i €181.7M
EPS i 0.61
P/E Ratio (TTM) i 22.89
Forward P/E i 4.24
P/B Ratio i 0.47
PEG Ratio i 4.24
Div. Yield i 2.31%
ROE i 1.25%
Beta i 0.756
Debt to Equity i 108.40

Financial Highlights

Profitability

Gross Margin i N/A
Operating Margin i 3.79%
Profit Margin i 0.94%

Returns and Earnings

Return on Assets (TTM) i 2.03%
Return on Equity (TTM) i 1.25%
EBITDA i €114.3M
Net Income (TTM) i €7.7M

Growth

Revenue (TTM) i
Revenue Per Share (TTM) i €65.13
Quarterly Revenue Growth (YoY) i -7.10%
Quarterly Earnings Growth (YoY) i -76.00%

Dividend Information

Last 12-Month Dividend i €0.50
Current Dividend Yield i 2.31%
3-Year Average Dividend Yield i 2.72%
3-Year Average Annual Dividend i €0.62
3-Year Total Dividends i €1.85
Ex-Dividend Date i July 1, 2024

Peer Performance Comparison

Performance comparison table showing returns for peer companies over various time periods
CompanyMarket Cap1W1M3M6MYTD1Y3Y5Y
Guerbet S.A GBT 181.67M Mid-cap6.40%-27.67%-37.54%-26.29%-47.91%-60.28%-14.57%-51.53%
Eurobio Scientific ALERS 256.89M Mid-cap0.99%0.99%1.19%4.07%0.99%-0.58%46.08%64.31%
Median Technologies ALMDT 121.65M Small-cap27.37%22.46%51.08%20.34%-17.69%-18.27%-51.05%-61.14%
Affluent Medical AFME 59.04M Small-cap-1.33%0.68%11.28%7.25%6.47%-15.43%-21.69%-81.38%
Implanet S.A ALIMP 55.44M Small-cap25.71%37.50%300.00%300.00%266.67%300.00%144.44%-47.62%
Diagnostic Medical ALDMS 35.52M Small-cap0.00%2.24%1.48%38.38%73.42%44.21%26.85%-17.47%

Ownership & Short Interest

Insider Ownership i 58.17%
Institutional Ownership i 14.88%
Shares Short i N/A
Short Ratio i N/A
Short % of Shares Outstanding i N/A
Average 10-Day Volume i 68K
Average 90-Day Volume i 40K

Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in would have performed over time.

If not specified, the latest available data will be used

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

In the last 52 weeks, Guerbet S.A reached a high of €39.35 (on October 21, 2024) and a low of €12.72 (on September 25, 2025).
Curious about Guerbet S.A's size and valuation? Its market capitalization stands at 181.67M. When it comes to valuation, the P/E ratio (trailing twelve months) is 22.89, and the forward P/E (looking ahead) is 4.24.
Yes, Guerbet S.A is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 2.31%, and the company has paid an average of €0.62 per share annually over the past 3 years.

When looking at Guerbet S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

CompanyMkt CapSectorIndustry1Y Return3Y Return
Eurobio Scientific
ALERS
256.89MHealthcareMedical Devices-0.58%46.08%
Median Technologies
ALMDT
121.65MHealthcareMedical Devices-18.27%-51.05%
Affluent Medical
AFME
59.04MHealthcareMedical Devices-15.43%-21.69%
Implanet S.A
ALIMP
55.44MHealthcareMedical Devices300.00%144.44%
Diagnostic Medical
ALDMS
35.52MHealthcareMedical Devices44.21%26.85%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

To get a sense of Guerbet S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 1.25%, the Debt to Equity ratio from the most recent quarter is 108.40, and its Gross Profit Margin stands at N/A.
Looking at Guerbet S.A's growth, its revenue over the trailing twelve months (TTM) was €821M. Compared to the same quarter last year (YoY), quarterly revenue grew by -7.10%, and quarterly earnings saw a YoY growth of -76.00%.
Wondering who owns Guerbet S.A stock? Company insiders (like executives and directors) hold about 58.17% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 14.88%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.